Molecular remission of FLT3-ITD(+) positive AML relapse after allo-SCT by acute GVHD in addition to sorafenib. (Q54602347)

1 June 2018

title

Molecular remission of FLT3-ITD(+) positive AML relapse after allo-SCT by acute GVHD in addition to sorafenib. (English)

1 reference

1 June 2018

author name string

W H Krüger

1

1 reference

1 June 2018

C Hirt

2

1 reference

1 June 2018

T Kiefer

3

1 reference

1 June 2018

T Neumann

4

1 reference

1 June 2018

C Busemann

5

1 reference

1 June 2018

G Dölken

6

1 reference

1 June 2018

language of work or name

English

0 references

publication date

21 March 2011

1 reference

1 June 2018

Bone Marrow Transplantation

published in

1 reference

1 June 2018

volume

47

1 reference

1 June 2018

page(s)

137-138

1 reference

1 June 2018

issue

1

1 reference

1 June 2018

https://scigraph.springernature.com/pub.10.1038/bmt.2011.7

exact match

0 references

cites work

Phase I/II study of combination therapy with sorafenib, idarubicin, and cytarabine in younger patients with acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.7

Compassionate use of sorafenib in FLT3-ITD-positive acute myeloid leukemia: sustained regression before and after allogeneic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.7

Allogeneic hematopoietic cell transplantation after fludarabine and 2 Gy total body irradiation for relapsed and refractory mantle cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.7

Detection of FLT3 Internal Tandem Duplication and D835 Mutations by a Multiplex Polymerase Chain Reaction and Capillary Electrophoresis Assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.7

21 January 2018

Identifiers

DOI

10.1038/BMT.2011.7

1 reference

1 June 2018

Dimensions Publication ID

0 references

1 reference

1 June 2018